AMBIT BIOSCIENCES

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pha... rma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.

#SimilarOrganizations #People #Financial #Website #More

AMBIT BIOSCIENCES

Social Links:

Linkedin

Industry:

Biopharma Biotechnology Health Care

Founded:

2000-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.ambitbio.com

Total Employee:

51+

Status:

Active

Contact:

(858) 334-2100

Email Addresses:

[email protected]

Total Funding:

215.73 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box Organization Schema

Similar Organizations

genelux-logo

Genelux

Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

otonomy-logo

Otonomy

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Advisors List

faheem-hasnain_image

Faheem Hasnain Board Chairman @ Ambit Biosciences
Board_member
2010-10-01

david-parkinson_image

David Parkinson Member of the Board of Directors @ Ambit Biosciences
Board_member
2013-01-01

standish-m-fleming_image

Standish M. Fleming Board Director @ Ambit Biosciences
Board_member
2001-01-01

steven-a-elms_image

Steven A. Elms Board Director @ Ambit Biosciences
Board_member

david-bonita_image

David Bonita Board Director @ Ambit Biosciences
Board_member

isai-peimer_image

Isai Peimer Board Director @ Ambit Biosciences
Board_member
2011-01-01

joseph-regan_image

Joseph Regan Member of the Board of Directors @ Ambit Biosciences
Board_member
2009-01-01

Current Employees Featured

alan-lewis_image

Alan Lewis
Alan Lewis President & CEO @ Ambit Biosciences
President & CEO

Founder

kevin-kinsella_image

Kevin Kinsella

Stock Details

Company's stock symbol is NASDAQ:AMBI

Investors List

apposite-capital_image

Apposite Capital

Apposite Capital investment in Venture Round - Ambit Biosciences

radius-ventures_image

Radius Ventures

Radius Ventures investment in Venture Round - Ambit Biosciences

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Venture Round - Ambit Biosciences

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Venture Round - Ambit Biosciences

gimv_image

Gimv

Gimv investment in Venture Round - Ambit Biosciences

forward-ventures_image

Forward Ventures

Forward Ventures investment in Venture Round - Ambit Biosciences

aisling-capital_image

Aisling Capital

Aisling Capital investment in Venture Round - Ambit Biosciences

medimmune-ventures_image

MedImmune Ventures

MedImmune Ventures investment in Venture Round - Ambit Biosciences

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Ambit Biosciences

forward-ventures_image

Forward Ventures

Forward Ventures investment in Series D - Ambit Biosciences

Investments List

Date	Company	Article	Money raised
2008-09-19	Afraxis	Ambit Biosciences investment in Series A - Afraxis	1.5 M USD

Official Site Inspections

http://www.ambitbio.com

Host Informations
Whois Informations

Loading ...

More informations about "Ambit Biosciences" on Search Engine